Evidence map›Paper›PMID 30166433›Full record

ArticleAJNR. American journal of neuroradiology2018

Multiple Brain Developmental Venous Anomalies as a Marker for Constitutional Mismatch Repair Deficiency Syndrome.

S I Shiran, L Ben-Sira, R Elhasid, J Roth, U Tabori, M Yalon, S Constantini, R Dvir

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Low-grade astrocytoma in the setting of a developmental venous anomaly.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

S I ShiranFrom the Departments of Radiology (S.I.S., L.B.-S.) shellyshiran@gmail.com.ORCID 0000-0001-5166-5107
L Ben-SiraFrom the Departments of Radiology (S.I.S., L.B.-S.).ORCID 0000-0002-0827-0190
R ElhasidPediatric Hematology/Oncology (R.E., R.D.).ORCID 0000-0002-5663-6919
J RothPediatric Neurosurgery (J.R., S.C.), Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-4267-8835
U TaboriDivision of Hematology/Oncology (U.T.), Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-5019-2683
M YalonDepartment of Pediatric Hematology/Oncology (M.Y.), Sheba Medical Center, Tel-Hashomer, Israel.ORCID 0000-0001-9832-7068
S ConstantiniPediatric Neurosurgery (J.R., S.C.), Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-3170-5295
R DvirPediatric Hematology/Oncology (R.E., R.D.).ORCID 0000-0002-9066-2934
Palmetto Hematology Oncology · USTel Aviv University · ILSheba Medical Center · ILShell (Netherlands) · NLS.P.E.C.I.E.S. · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeBiallelic constitutional mutations in DNA mismatch repair genes cause a distinct syndrome, constitutional mismatch repair deficiency syndrome (CMMRD), characterized by cancers from multiple organs, most commonly brain tumors, during childhood. Surveillance protocols include total and brain MR imaging among other modalities to enable early detection of tumors. Brain surveillance scans revealed prominent brain developmental venous anomalies (DVAs) in some patients. DVAs are benign vascular anomalies, and their incidence in the general population is 2.6%-6.4%. Most developmental venous anomalies are asymptomatic and are found incidentally. Our purpose was to assess the prevalence of DVAs in CMMRD patients and describe their phenotype. MATERIALS AND

methodsA retrospective descriptive analysis of brain MR imaging studies from 10 patients from 3 families with CMMRD was performed. Analysis included the number of developmental venous anomalies, location, draining vessels, and associated vascular anomalies (ie, cavernomas), with clinical correlation of symptoms and tumors.

resultsAll 10 patients had ≥2 developmental venous anomalies, and 2 had, in addition, non-therapy-induced cavernomas. There was no clinically symptomatic intracranial bleeding from developmental venous anomalies. Six patients had malignant brain tumors. The location of brain tumors was not adjacent to the developmental venous anomalies. No new developmental venous anomalies developed during follow-up.

conclusionsThe occurrence of multiple developmental venous anomalies in all our patients with CMMRD suggests that developmental venous anomalies may be a characteristic of this syndrome that has not been previously described. If confirmed, this quantifiable feature can be added to the current scoring system and could result in early implementation of genetic testing and surveillance protocols, which can be life-saving for these patients.

Indexed as

Brain NeoplasmsCerebral VeinsChildChild, PreschoolColorectal NeoplasmsDNA Mismatch RepairFemaleHemangioma, Cavernous, Central Nervous SystemHumansInfantMaleNeoplastic Syndromes, HereditaryPhenotypeRetrospective Studies

Identifiers

PMID30166433
PMCPMC7410739
OpenAlexW2889309496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.